Vaccine maker Seqirus plots $800M investment into major Australian shot manufacturing center

Vaccine maker Seqirus plots $800M investment into major Australian shot manufacturing center

Source: 
Fierce Pharma
snippet: 

As one of the largest flu vaccine makers in the world, Seqirus is working overtime to churn out doses amid a key influenza season. Even with demand at an all-time high, the company is also looking to the future—and it's chosen Australia as the home of an ambitious manufacturing center.